DZ Bank
VKTXW

DZ Bank’s Viking Therapeutics, Inc. VKTXW Stock Holding History

DZ Bank’s Portfolio VKTXW Stock Details VKTXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-74,285
Closed -$230K – 1154
2018
Q1 		$230K Buy
+74,285
New +$304K ﹤0.01% 909

Other funds holding VKTXW

William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

DZ Bank's VKTXW Position: Q2 2018 in Review

DZ Bank sold out of Viking Therapeutics, Inc. (VKTXW) in Q2 2018, closing a stake of 74,285 shares — an estimated $230K sold.

DZ Bank first reported a position in VKTXW in Q1 2018 and held it in 1 quarter. The position peaked at $230K in Q1 2018. 4 funds tracked by Wall St. Rank hold VKTXW as of Q2 2018.

  • DZ Bank reported no remaining Viking Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • DZ Bank sold 74,285 Viking Therapeutics, Inc. shares in Q2 2018, an estimated $230K.
  • DZ Bank first reported a position in Viking Therapeutics, Inc. in Q1 2018 and held it in 1 quarter.
  • DZ Bank's Viking Therapeutics, Inc. position peaked at $230K in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Viking Therapeutics, Inc. as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.